Skip to content
Research Article Open access CC BY 4.0

First Study of scpB Gene of Streptococcus agalactiae in Misiones, Argentina

M. E. Laczesk, M. G. Novosak, M. I. Vergara

Microbiology Research Journal International · pp. 499–506 · Published 13 May 2015

10.9734/BMRJ/2015/17956

Abstract

Aims: Streptococcus agalactiae (GBS) is the leading cause of neonatal infections. GBS presents different surface proteins of antigenic characteristics. These proteins are encoded by several genes associated with virulence and host interaction acting on bacteria involved in invasiveness. The study of these surface protein antigens is important for the understanding of the pathogenesis and epidemiology of the infection. Several of these antigens have been proposed as components of multivalent conjugate vaccines. This study focuses on the presence of scpB gene encoding the C5a peptidase in GBS. Recent studies indicate that C5a peptidase vaccine formulations cause a long-term immune response and prevent GBS infection. Methodology: A total of 200 Streptococcus agalactiae isolates were collected from vaginal or rectal swabs of pregnant women with 35 – 37 weeks gestational age. Conventional biochemical tests and commercial kits for latex particle agglutination (Phadebact Strep B Test-ETC-Bactus International AB Sweden) were used to identify those isolates. GBS strains were preserved in 20% skim milk at -80°C and were recovered to search the gene scpB. The scpB gene was investigated by conventional PCR. PCR products were visualized on 2% agarose gel gel stained with GelRed® (Biotium, Inc.; US) and visualized of bands in UV trans illuminator (MUV Model 21-312-220), using MP (D0017 marker DNA fragments made up of 10 double-stranded DNA molecular size of 100 to 1000 pb-INBIO, Argentina). Results: The presence of the scpB gene was detected in 100% of Streptococcus agalactiae strains studied. Conclusion: Our findings highlight the importance of including C5a peptidase in the design of a regional vaccine. The high specificity of the scpB gene in GBS, and the lack of homologous sequences in other bacterial genera and species, makes it a molecular marker that can be used in the diagnosis of colonization or infection by this microorganism.

Streptococcus agalactiae ScpB gene

References (38)

  1. 1 Streptococcus Adherence and Colonization [DOI]
  2. 2 Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms [DOI]
  3. 3 Increasing Burden of Invasive Group B Streptococcal Disease in Nonpregnant Adults, 1990–2007 [DOI]
  4. 4 Surface Proteins ofStreptococcus agalactiaeand Related Proteins in Other Bacterial Pathogens [DOI]
  5. 5 Serotype IX, a Proposed New Streptococcus agalactiae Serotype [DOI]
  6. 6 Group B Streptococcus Engages an Inhibitory Siglec through Sialic Acid Mimicry to Blunt Innate Immune and Inflammatory Responses In Vivo [DOI]
  7. 7 Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility [DOI]
  8. 8 FATAL INFECTIONS BY HqMOLYTIC STREPTOCOCCUS GROUP B [DOI]
  9. 9 Identification of Novel Adhesins from Group B Streptococci by Use of Phage Display Reveals that C5a Peptidase Mediates Fibronectin Binding [DOI]
  10. 10 Invasive Group B Streptococcal Disease in Non-pregnant Adults [DOI]
  11. 11 Invasive Group B Streptococcal Infections in Infants, France [DOI]
  12. 12 Conservation of the C5a peptidase genes in group A and B streptococci [DOI]
  13. 13 Horizontal gene transfer and host specificity of beta‐haemolytic streptococci: the role of a putative composite transposon containing scpB and lmb [DOI]
  14. 14 Serotypes, Antibiotic Susceptibilities, and Multi-Locus Sequence Type Profiles of Streptococcus agalactiae Isolates Circulating in Beijing, China [DOI]
  15. 15 A maternal vaccine against group B Streptococcus: Past, present, and future [DOI]
  16. 16 Antimicrobial susceptibility profiles, serotype distribution and virulence determinants among invasive, non-invasive and colonizing Streptococcus agalactiae (group B streptococcus) from Malaysian patients [DOI]
  17. 17 Bacterial virulence factors in neonatal sepsis: group B streptococcus [DOI]
  18. 18 Genotypes and Virulence Genes in Group B Streptococcus Isolated in the Maternity Hospital, Kuwait [DOI]
  19. 19 Interactions of the streptococcal C5a peptidase with human fibronectin [DOI]
  20. 20 Structure of the streptococcal cell wall C5a peptidase [DOI]
  21. 21 Vaccination against Group B streptococcus [DOI]
  22. 22 The frequency of genes encoding three putative group B streptococcal virulence factors among invasive and colonizing isolates [DOI]
  23. 23 MATERNAL AND NEONATAL SCREENING FOR GROUP B STREPTOCOCCI BY SCP B GENE BASED PCR: A PRELIMINARY STUDY [DOI]
  24. 24 Virulence factors, antimicrobial susceptibility and molecular characterization of Streptococcus agalactiae isolated from pregnant women [DOI]
  25. 25 Clinical diagnosis of group B streptococci by scpB gene based PCR.
  26. 26 Human Serum Induces Streptococcal C5a Peptidase Expression [DOI]
  27. 27 Protective immunization in mice against group B streptococci using encapsulated C5a peptidase [DOI]
  28. 28 Efficacy of polymeric encapsulated C5a peptidase–based group B streptococcus vaccines in a murine model [DOI]
  29. 29 Group B streptococcal bacteremia in a major teaching hospital in Malaysia: a case series of eighteen patients [DOI]
  30. 30 Genetic Polymorphisms of Group B StreptococcusscpBAlter Functional Activity of a Cell-Associated Peptidase That Inactivates C5a [DOI]
  31. 31 Comparative genetic study of group B streptococcal strains of human and bovine origin [DOI]
  32. 32 Central nervous system involvement in adult patients with invasive infection caused by Streptococcus agalactiae [DOI]
  33. 33 Serotipos y patrones de resistencia antibiótica en aislados betahemolíticos de Streptococcus agalactiae de madres colonizadas y recién nacidos con enfermedad invasiva [DOI]
  34. 34 Group B streptococci as an unusual cause of septic arthritis of the hip: association with childbirth [DOI]
  35. 35 Evolución de la sepsis neonatal precoz por Streptococcus agalactiae en el área de Barcelona (2004-2010). Análisis de los fallos del cumplimiento del protocolo de prevención [DOI]
  36. 36 Emergence of a hypervirulent neonatal pathogen [DOI]
  37. 37 Case Report: Group B Streptococcus meningitis in an adolescent [DOI]
  38. 38 Molecular epidemiology of group B streptococcal infections [DOI]

Cited by 3

Global patterns of antibiotic resistance in group B Streptococcus: a systematic review and meta-analysis

Chou-Yi Hsu, Safoura Moradkasani, Muath Suliman · Frontiers in Microbiology · 2025

Microbes and Infectious Diseases

H. Hassan, Abeer S. Hassan, Noha M. S. Abdelazim

Article metrics

Real usage data collected on this platform.

20

Page views

0

PDF downloads

4

Outbound clicks

3

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.